Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions.
about
Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition timeQuantification of heterogeneity as a biomarker in tumor imaging: a systematic reviewThe performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysisClassification of cerebral lymphomas and glioblastomas featuring luminance distribution analysisDiagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis.Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas.Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging.Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.Imaging in neuro-oncology.Differentiation of Brain Metastases and Gliomas Based on Color Map of Phase Difference Enhanced Imaging[F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [F]FDG in human xenograft models
P2860
Q31143153-C5FBE464-5FAD-4989-A8F2-11302BE4CBC2Q34946279-816A6663-373A-4E81-8F6D-2B652C278B14Q35175935-5277E0C1-CE0E-4EAC-A83E-4C260D229A5CQ35350679-B27A03D9-089D-484F-9D9D-805C3E3037FBQ36310471-D62721F5-919F-481A-B068-5C3AE945F84AQ36948495-429CA54C-6A7C-4985-834E-DA70E55F6094Q38780459-5E3A4821-A97C-41F3-B90A-0C8A0D4ECB49Q41461217-2CBF0E9D-7E7D-44FD-B692-5DB5E9DE8BBAQ45401713-4970101F-A020-4D2B-98A7-05B9908C784AQ48124356-6A4E9E9B-77B1-4E9B-B7EB-6844D7978115Q48194992-1F30C975-8C5E-487A-9CBD-18BC3989F437Q48457554-C00B7677-48FF-4370-95C3-1D413B9AD07AQ48715142-FD0EE9BF-88DC-4EF7-98DC-A4530AD06ADDQ54973707-2A2D9431-7801-43FC-BA53-B314FF4D7124Q57300037-0812C714-D6EA-4B53-88C6-5BE89B3C98D4Q58788935-0010F3A2-FC85-4843-B8C6-8606A8A2440D
P2860
Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Differentiation among glioblas ...... ing and perienhancing lesions.
@en
Differentiation among glioblas ...... ing and perienhancing lesions.
@nl
type
label
Differentiation among glioblas ...... ing and perienhancing lesions.
@en
Differentiation among glioblas ...... ing and perienhancing lesions.
@nl
prefLabel
Differentiation among glioblas ...... ing and perienhancing lesions.
@en
Differentiation among glioblas ...... ing and perienhancing lesions.
@nl
P2093
P2860
P356
P1476
Differentiation among glioblas ...... ing and perienhancing lesions.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A2161
P577
2010-06-25T00:00:00Z